Patent ID: 11860165
Assignee: GO THERAPEUTICS, INC.
Field: Measurement (Instruments)
Classification: CPC G  A  C | IPC C  G

Claim 21:
22. A method for detecting a Core3-MUC1-expressing cancer in a subject comprising:
(a) contacting a sample from the subject with the Core3-MUC1 binding polypeptide of claim 1;
(b) removing unbound sample from the Core3-MUC1 binding polypeptide or unbound Core3-MUC1 binding polypeptide from the sample; and
(c) characterizing the binding of the Core3-MUC1 binding polypeptide to the sample, wherein binding of the Core3-MUC1 binding polypeptide to the sample is indicative of cancer in the subject.